These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9043663)

  • 1. Synthesis and conformational analysis of peptide inhibitors of farnesyltransferase.
    Byk G; Lelievre Y; Duchesne M; Clerc FF; Scherman D; Guitton JD
    Bioorg Med Chem; 1997 Jan; 5(1):115-24. PubMed ID: 9043663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitors.
    Qian Y; Vogt A; Sebti SM; Hamilton AD
    J Med Chem; 1996 Jan; 39(1):217-23. PubMed ID: 8568811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of semipeptoid farnesyltransferase inhibitors.
    Reuveni H; Gitler A; Poradosu E; Gilon C; Levitzki A
    Bioorg Med Chem; 1997 Jan; 5(1):85-92. PubMed ID: 9043660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of characteristic lipopeptides of the human N-Ras protein and their evaluation as possible inhibitors of protein farnesyl transferase.
    Stöber P; Schelhaas M; Nägele E; Hagenbuch P; Rétey J; Waldmann H
    Bioorg Med Chem; 1997 Jan; 5(1):75-83. PubMed ID: 9043659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-peptide mimetic of Ras-CAAX: selective inhibition of farnesyltransferase and Ras processing.
    Vogt A; Qian Y; Blaskovich MA; Fossum RD; Hamilton AD; Sebti SM
    J Biol Chem; 1995 Jan; 270(2):660-4. PubMed ID: 7822292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclopropane-derived peptidomimetics. design, synthesis, and evaluation of novel Ras farnesyltransferase inhibitors.
    Hillier MC; Davidson JP; Martin SF
    J Org Chem; 2001 Mar; 66(5):1657-71. PubMed ID: 11262110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti tumor activity of farnesyl transferase inhibitor].
    Yoshimatsu K; Nagasu T
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):145-55. PubMed ID: 9030225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and structural requirements of potent peptidomimetic inhibitors of p21ras farnesyltransferase.
    Qian Y; Blaskovich MA; Saleem M; Seong CM; Wathen SP; Hamilton AD; Sebti SM
    J Biol Chem; 1994 Apr; 269(17):12410-3. PubMed ID: 8175645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
    Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
    J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesyl-derived inhibitors of ras farnesyl transferase.
    Kang MS; Stemerick DM; Zwolshen JH; Harry BS; Sunkara PS; Harrison BL
    Biochem Biophys Res Commun; 1995 Dec; 217(1):245-9. PubMed ID: 8526918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational restriction of flexible ligands guided by the transferred noe experiment: potent macrocyclic inhibitors of farnesyltransferase.
    Dinsmore CJ; Bogusky MJ; Culberson JC; Bergman JM; Homnick CF; Zartman CB; Mosser SD; Schaber MD; Robinson RG; Koblan KS; Huber HE; Graham SL; Hartman GD; Huff JR; Williams TM
    J Am Chem Soc; 2001 Mar; 123(9):2107-8. PubMed ID: 11456854
    [No Abstract]   [Full Text] [Related]  

  • 12. Kurasoins A and B, new protein farnesyltransferase inhibitors produced by Paecilomyces sp. FO-3684. II. Structure elucidation and total synthesis.
    Uchida R; Shiomi K; Sunazuka T; Inokoshi J; Nishizawa A; Hirose T; Tanaka H; Iwai Y; Omura S
    J Antibiot (Tokyo); 1996 Sep; 49(9):886-9. PubMed ID: 8931722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudopeptide inhibitors of Ras farnesyl-protein transferase.
    Graham SL; deSolms SJ; Giuliani EA; Kohl NE; Mosser SD; Oliff AI; Pompliano DL; Rands E; Breslin MJ; Deana AA
    J Med Chem; 1994 Mar; 37(6):725-32. PubMed ID: 8145221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-cyanocinnamide derivatives: a new family of non-peptide, non-sulfhydryl inhibitors of Ras farnesylation.
    Poradosu E; Gazit A; Reuveni H; Levitzki A
    Bioorg Med Chem; 1999 Aug; 7(8):1727-36. PubMed ID: 10482464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitors.
    Qian Y; Marugan JJ; Fossum RD; Vogt A; Sebti SM; Hamilton AD
    Bioorg Med Chem; 1999 Dec; 7(12):3011-24. PubMed ID: 10658608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of farnesyltransferase and Ras processing peptidase.
    Hall CC; Watkins JD; Ferguson SB; Foley LH; Georgopapadakou NH
    Biochem Biophys Res Commun; 1995 Dec; 217(3):728-32. PubMed ID: 8554591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel conformationally extended naphthalene-based inhibitors of farnesyltransferase.
    Burns CJ; Guitton JD; Baudoin B; Lelièvre Y; Duchesne M; Parker F; Fromage N; Commerçon A
    J Med Chem; 1997 Jun; 40(12):1763-7. PubMed ID: 9191950
    [No Abstract]   [Full Text] [Related]  

  • 18. Design, synthesis and early structure-activity relationship of farnesyltransferase inhibitors which mimic both the peptidic and the prenylic substrate.
    Schlitzer M; Böhm M; Sattler I; Dahse HM
    Bioorg Med Chem; 2000 Aug; 8(8):1991-2006. PubMed ID: 11003144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Arylalkyl pseudopeptide inhibitors of farnesyltransferase.
    deSolms SJ; Giuliani EA; Graham SL; Koblan KS; Kohl NE; Mosser SD; Oliff AI; Pompliano DL; Rands E; Scholz TH; Wiscount CM; Gibbs JB; Smith RL
    J Med Chem; 1998 Jul; 41(14):2651-6. PubMed ID: 9651171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. J-104,871, a novel farnesyltransferase inhibitor, blocks Ras farnesylation in vivo in a farnesyl pyrophosphate-competitive manner.
    Yonemoto M; Satoh T; Arakawa H; Suzuki-Takahashi I; Monden Y; Kodera T; Tanaka K; Aoyama T; Iwasawa Y; Kamei T; Nishimura S; Tomimoto K
    Mol Pharmacol; 1998 Jul; 54(1):1-7. PubMed ID: 9658183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.